Research paper efficacy and safety of telitacicept combined with standard therapy for lupus nephritis: a single-center real-world study
BackgroundLupus nephritis (LN) is a severe complication of systemic lupus erythematosus with suboptimal response to standard therapy. This study evaluated the efficacy and safety of telitacicept, a novel fusion protein targeting both BLyS and APRIL, co…